Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study (scientific article published on 31 July 2018)

Computed tomography findings in invasive pulmonary aspergillosis in non-neutropenic transplant recipients and neutropenic patients, and their prognostic value

Q84796007

The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis

Q28077490

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

Q28217179

Invasive aspergillosis in the intensive care unit

Q28306909

The co-pathogenesis of influenza viruses with bacteria in the lung.

Q30359731

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection

Q30388857

Bench-to-bedside review: bacterial pneumonia with influenza - pathogenesis and clinical implications

Q30389010

Bacterial pneumonia as an influenza complication

Q30396561

Influenza-Associated Aspergillosis in Critically Ill Patients.

Q30400852

Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients

Q30406357

Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

Q33828888

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

Q34532546

Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study

Q36886708

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

Q37164067

Invasive Aspergillosis Associated With Severe Influenza Infections

Q37305560

Post-influenza aspergillosis, do not underestimate influenza B.

Q37671496

H1N1: viral pneumonia as a cause of acute respiratory distress syndrome

Q37820852

Approach to invasive pulmonary aspergillosis in critically ill patients

Q38186970

Hypoxia attenuates anti-Aspergillus fumigatus immune responses initiated by human dendritic cells

Q39896573

Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer

Q40107589

Higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections

Q40159414

Increased incidence of co-infection in critically ill patients with influenza

Q40515346

Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients

Q41998776

Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study

Q43631437

Immunoparalysis as a cause for invasive aspergillosis?

Q43798573

A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients

Q46059175

Fungal infections in adult patients on extracorporeal life support.

Q54233900

Galactomannan in Bronchoalveolar Lavage Fluid

Q57559940

Comparison of premortem clinical diagnoses in critically iII patients and subsequent autopsy findings

Q73892686

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

invasive aspergillosis

intensive care unit

number of pages

page(s)

782-792

P577

publication date

2018-07-31

P1433

published in

The Lancet. Respiratory medicine

Q27724908

P1476

title

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study

P478

volume

Reverse relations

cites work (P2860)

Q89509794	Blood Aspergillus PCR: The Good, the Bad, and the Ugly
Q96129491	COVID-19-associated invasive pulmonary aspergillosis
Q96026875	Co-infections in people with COVID-19: a systematic review and meta-analysis
Q99615038	Colistin and Isavuconazole Interact Synergistically In Vitro against Aspergillus nidulans and Aspergillus niger
Q91979642	Concomitant severe influenza and cryptococcal infections: A case report and literature review
Q104492457	Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
Q90674807	Development and Applications of Prognostic Risk Models in the Management of Invasive Mold Disease
Q98657590	Diagnosing COVID-19-associated pulmonary aspergillosis
Q92082086	Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens
Q110696307	Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance
Q91981918	Estimated Burden of Serious Fungal Infections in Ghana
Q99623411	Fatal aspergillosis complicating severe SARS-CoV-2 infection: A case report
Q104268469	Fungal infections should be part of the core outcome set for COVID-19
Q107473554	Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs
Q92328257	Immune Parameters for Diagnosis and Treatment Monitoring in Invasive Mold Infection
Q97562406	Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients
Q91762013	Influenza H1N1 infection in immunocompromised host: A concise review
Q90486818	Influenza Infections and Emergent Viral Infections in Intensive Care Unit
Q98165023	Influenza challenging the diagnosis and management of pulmonary coccidioidomycosis
Q64124467	Influenza coinfection: be(a)ware of invasive aspergillosis
Q96138684	Influenza-associated aspergillosis in critically-ill patients-a retrospective bicentric cohort study
Q90242380	International survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: responses suggest low awareness and potential underdiagnosis outside Europe
Q92498075	Invasive Fungal Infection
Q92051268	Invasive fungal diseases during COVID-19: We should be prepared
Q94571420	Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report
Q90422643	Knowledge of Infectious Disease Specialists Regarding Aspergillosis Complicating Influenza, United States
Q90746014	Let's add invasive aspergillosis to the list of influenza complications
Q90628627	Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus-specific Lateral Flow Device test in bronchoalveolar lavage
Q95643389	Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19
Q93053154	Prophylaxis of mould infections
Q99611492	Putative Invasive Pulmonary Aspergillosis in Critically Ill Patients with COVID-19: An Observational Study from New York City
Q90265273	Revealing the Virulence Potential of Clinical and Environmental Aspergillus fumigatus Isolates Using Whole-Genome Sequencing
Q92484231	Severe flu management: a point of view
Q100395204	Short course of voriconazole therapy as a risk factor for relapse of invasive pulmonary aspergillosis
Q57791873	Steroids and severe pneumonia. Ready for the winter? Discussion on "Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study"
Q60936421	The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation
Q99731377	Understanding the role of bacterial and fungal infection in COVID-19
Q90290966	Understanding the role of host response in influenza pneumonitis
Q90209497	Ventilator-associated pneumonia in adults: a narrative review

P356	DOI	10.1016/S2213-2600(18)30274-1
P698	PubMed publication ID	30076119